ibandronic acid has been researched along with Acute-Phase Reaction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buffat, H; Curkovic, I; Lippuner, K; Popp, AW; Popp, PF; Senn, C; Senn, R | 1 |
| Burkiewicz, JS; Fit, KE; Griffin, BL; Meyer, CM | 1 |
| Kraenzlin, CA; Kraenzlin, ME; Lardelli, P; Meier, C; Sieber, P | 1 |
| Civitelli, R; Emkey, R; Strampel, W | 1 |
1 review(s) available for ibandronic acid and Acute-Phase Reaction
| Article | Year |
|---|---|
Safety considerations with bisphosphonates for the treatment of osteoporosis.
Topics: Acute-Phase Reaction; Administration, Oral; Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Gastrointestinal Diseases; Humans; Ibandronic Acid; Injections, Intravenous; Jaw Diseases; Osteonecrosis; Osteoporosis, Postmenopausal; Renal Insufficiency; Risedronic Acid | 2007 |
3 other study(ies) available for ibandronic acid and Acute-Phase Reaction
| Article | Year |
|---|---|
Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
Topics: Acute-Phase Reaction; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Risk Factors; Severity of Illness Index; Zoledronic Acid | 2017 |
Acute phase reaction with intravenous ibandronate.
Topics: Acute-Phase Reaction; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Injections, Intravenous; Middle Aged; Osteoporosis, Postmenopausal | 2008 |
Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Topics: Acute-Phase Reaction; Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Female; Humans; Ibandronic Acid; Imidazoles; Incidence; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Zoledronic Acid | 2013 |